| Comparison of cost-effectiveness acceptability curves (CEAC) in modeled analyses with and without established heterogeneity of patient characteristics. |
| Author(s): Foos V, McEwan P, Lamotte M |
| Affiliations(s): |
| Publication(s): 22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Diabetes
2017 |
|
L:
A: |
English
Cost effectiveness |
|
 |
| |
| |
| Estimating glomerular filtration rate in primary care electronic medical record databases in Europe |
| Author(s): Jouaville SL1, Bizouard G1, Boutmy E1, Keja J2
|
| Affiliations(s): 1QuintilesIMS, Boulogne Billancourt, France, 2QuintilesIMS, Rotterdam, Netherlands |
| Publication(s): 22nd ISPOR Annual International Meeting, Boston, 2017 |
| Document Type(s): Abstract |
| Countries: Germany, UK |
C:
Y: |
Diabetes, Methodology, Nephrology
2017 |
|
L:
A: |
English
Clinical setting: Primary care, Retrospective database analysis |
|
|
| |
| |
| Assessing the economic burden of type 2 diabetes in China reflecting the current standard of the disease management and for improved management scenarios using a modeling approach. |
| Author(s): Foos V1, Lamotte M1, McEwan P4, Jiang X3, Zhang YL3, Qu S2, De Moor R1, Ramos R1, Xiong T2, Wang K3 |
| Affiliations(s): 1 IMS Health, Brussels, Belgium 2 IMS Health, Shanghai, China 3 Eli Lilly, Shanghai, China 4 Swansea University, Wales |
| Publication(s): 22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA |
| Document Type(s): Abstract |
| Countries: China |
C:
Y: |
Diabetes
2017 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Approaches to standardizing cardiovascular risk equation endpoints in order to facilitate their inclusion within a type 2 diabetes model. |
| Author(s): McEwan P, Foos V, Lamotte M |
| Affiliations(s): |
| Publication(s): 22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Diabetes
2017 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Etude DISCOVER France - étude enrichie visant à décrire la prise en charge des patients diabétiques de type 2 |
| Author(s): Harmand S.1, Maillard C.1, Thomas F.2 |
| Affiliations(s): 1. QuintilesIMS, La Défense, France. 2. Astra Zeneca, La Défense, France
|
| Publication(s): ADELF-SFSP congress (l'Association des épidémiologistes de langue française - Société française de santé publique) June 2017 in France |
| Document Type(s): Abstract, Poster |
| Countries: France |
C:
Y: |
Diabetes
2017 |
|
L:
A: |
French
Clinical setting: Primary care, Longitudinal study, Observational study, Patient questionnaire, Quality of life, Real World Data |
|
|
| |
| |
| Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden |
| Author(s): Lind M1,2, Matsson PO3, Linder R4, Svenningsson I5, Jørgensen L6, Ploug UJ7, Gydesen H7, Dorkhan M8, Larsen S8, Johansson G9. |
| Affiliations(s): 1Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden. lind.marcus@telia.com.
2Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. lind.marcus@telia.com.
3Domnarvet VC, Borlänge, Sweden.
4Pygargus, Stockholm, Sweden.
5Research and Development Unit, Primary Health Care, Närhälsan, Vänersborg, Sweden.
6IMS Health, Stockholm, Sweden.
7Novo Nordisk A/S, Søborg, Denmark.
8Novo Nordisk Scandinavia AB, Malmö, Sweden.
9Department of Caring Sciences and Family Medicine, Uppsala University, Uppsala, Sweden. |
| Publication(s): Diabetes Ther |
| Document Type(s): Article |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Diabetes
2016 |
|
L:
A: |
English
Retrospective cohort analysis |
|
|
| |
| |
| Implications of introducing patient heterogeneity in cost effectiveness modeling. |
| Author(s): Foos V1, McEwan P2, Lamotte M3
|
| Affiliations(s): 1 IMS Health, Zaventem, Belgium 2 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom 3 IMS Health, Vilvoorde, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Diabetes
2016 |
|
L:
A: |
English
Methodology |
|
|
| |
| |
| Replacing input probability distributions with mean values can bias simulation output: an illustration using the Core Diabetes Model. |
| Author(s): McEwan P1, Foos V2, Lamotte M3 |
| Affiliations(s): 1 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom 2 IMS Health, Zaventem, Belgium, 3 IMS Health, Vilvoorde, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Diabetes
2016 |
|
L:
A: |
English
Methodology |
|
|
| |
| |
| Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study. |
| Author(s): Lefebvre P1, Pilon D1, Robitaille MN1, Lafeuille MH1, Chow W2, Pfeifer M2, Duh MS3. |
| Affiliations(s): 1a Groupe d'analyse, Ltée , Montréal , Québec , Canada ;
2b Janssen Scientific Affairs, LLC , Raritan , NJ , USA ;
3c Analysis Group, Inc. , Boston , MA , USA. |
| Publication(s): Curr Med Res Opin. 2016 Jun;32(6):1151-9 |
| Document Type(s): Article |
| Countries: USA |
| Click here for the abstract |
C:
Y: |
Diabetes
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes |
| Author(s): Anyanwagu U, Mamza J, Mehta R, Donnelly R, Idris I |
| Affiliations(s): Division of Medical Sciences & Graduate Entry Medicine, School of Medicine; Research Design Services (East Midlands), School of Medicine |
| Publication(s): |
| Document Type(s): Article |
| Countries: UK |
C:
Y: |
Cardiovascular disease, Diabetes, Miscellaneous
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
 1 of 47 
|
